Maria Chatzopoulou

University of Oxford

United Kingdom

Research Interests

Explore related searches

Professors in United Kingdom

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

Articles (14)

Year:

2025

Year:

2025

Year:

2024

Year:

2024

Year:

2022

Year:

2022

Year:

2021

Year:

2020

Year:

2020

Year:

2020

Year:

2020

Year:

2020

Year:

2020

Year:

2020

Collaborators (9)

R. Fernando Martínez

SPAIN

View details

Lee Moir

University of Oxford

UNITED KINGDOM

View details

Jakob Lang

University of Zurich

SWITZERLAND

View details

Simon Guiraud

University of Oxford

UNITED KINGDOM

View details

Herana Kamal Seneviratne

Assistant Professor

University of Maryland Baltimore County

UNITED STATES

View details

Katrina S. Madden

Newcastle University

UNITED KINGDOM

View details

Kay Davies

Founder Member (with Profs M Wood and K Talbot)

University of Oxford

UNITED KINGDOM

View details

Graham M. Wynne

University of Oxford

UNITED KINGDOM

View details

Hannah Fox Dugdale

Lecturer in Molecular and Cellular Physiology

Loughborough University

UNITED KINGDOM

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Maria Chatzopoulou

Research Interests

Explore related searches

Contact this professor

Articles (14)

Bioactivation and reactivity research advances—2024 year in review

Biotransformation research advances – 2024 year in review

Bioactivation and reactivity research advances – 2023 year in review

Biotransformation research advances – 2023 year in review

Pilot Study to Quantify Palladium Impurities in Lead-like Compounds Following Commonly Used Purification Techniques

Structure-activity relationships of 2-pyrimidinecarbohydrazides as utrophin modulators for the potential treatment of Duchenne muscular dystrophy

Discovery and mechanism of action studies of 4,6-diphenylpyrimidine-2-carbohydrazides as utrophin modulators for the treatment of Duchenne muscular dystrophy

Decreasing HepG2 Cytotoxicity by Lowering the Lipophilicity of Benzo[d]oxazolephosphinate Ester Utrophin Modulators

2-Arylbenzo[d]oxazole Phosphinate Esters as Second-Generation Modulators of Utrophin for the Treatment of Duchenne Muscular Dystrophy

Isolation, Structural Identification, Synthesis, and Pharmacological Profiling of 1,2-trans-Dihydro-1,2-diol Metabolites of the Utrophin Modulator Ezutromid

Chemical Proteomics and Phenotypic Profiling Identifies the Aryl Hydrocarbon Receptor as a Molecular Target of the Utrophin Modulator Ezutromid

Chemical Proteomics and Phenotypic Profiling Identifies the Aryl Hydrocarbon Receptor as a Molecular Target of the Utrophin Modulator Ezutromid

Synthesis of SMT022357 enantiomers and in vivo evaluation in a Duchenne muscular dystrophy mouse model

From diagnosis to therapy in Duchenne muscular dystrophy

Collaborators (9)

R. Fernando Martínez

Lee Moir

Jakob Lang

Simon Guiraud

Herana Kamal Seneviratne

Katrina S. Madden

Kay Davies

Graham M. Wynne

Hannah Fox Dugdale

Make your next move.